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ABSTRACT
Purpose: To qualify the FT-Raman spectral data of primary and metastatic cutaneous melanoma in order to obtain a differential
diagnosis. Methods: Ten normal human skin samples without any clinical or histopathological alterations, ten cutaneous melanoma
fragments, and nine lymph node metastasis samples were used; 105, 140 and 126 spectra were obtained respectively. Each sample was
divided into 2 or 3 fragments of approximately 2 mm3 and positioned in the Raman spectrometer sample holder in order to obtain the
spectra; a monochrome laser light Nd:YAG at 1064 nm was used to excite the inelastic effect. Results: To differentiate the three
histopathological groups according to their characteristics extracted from the spectra, data discriminative analysis was undertaken.
Phenylalanine, DNA, and Amide-I spectral variables stood out in the differentiation of the three groups. The percentages of correctly
classified groups based on Phenylalanine, DNA, and Amide-I spectral features was 93.1%. Conclusion: FT-Raman spectroscopy is
capable of differentiating melanoma from its metastasis, as well as from normal skin.
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RESUMO
Objetivo: Qualificar os dados espectrais FT-Raman do melanoma cutâneo primário e metastático e assim realizar o diagnóstico diferencial.
Métodos: Foram utilizadas amostras de 10 fragmentos de pele sem alterações clínicas ou histopatológicas, 10 de melanomas cutâneos
e 9 de metástases linfonodais; 105, 140 and 126  espectros foram obtidos respectivamente. Cada amostra foi dividida em 2 ou 3 frações
de 2 mm3 e posicionada no porta amostras do espectrômetro Raman para obtenção dos espectros, por meio da excitação do espalhamento
inelástico pelo laser de Nd:YAG em 1064 nm incididos na amostra. Resultados: Para diferenciar os três grupos formados de acordo
com as características fornecidas pelos espectros, realizamos a análise discriminante dos dados. As variáveis espectrais Fenilalanina,
DNA e Amida-I se destacaram na capacidade de diferenciação dos três grupos histológicos. A porcentagem de classificação correta
utilizando estes critérios foi de 93,1%; o que mostra a eficiência da análise realizada. Conclusão: A espectroscopia FT-Raman é capaz
de diferenciar o melanoma de sua metástase, assim como da pele normal.
Descritores: Melanoma. Análise Espectral Raman. Diagnóstico. Biópsia.
1Research performed at the Plastic Surgery Experimental Laboratory, Post-graduate Program in Plastic Surgery, Division of Plastic Surgery,
Department of Surgery, Federal University of Sao Paulo (UNIFESP), Brazil.
Introduction
Raman spectroscopy is an optical technique that
provides information on the vibrational levels of molecules. It is
widely used in analytical studies, both qualitative and quantitative.
With Raman spectroscopy the molecular structure and composition
of the material under study is coded as a group of spread light
frequency changes.  Thus, the Raman spectrum can provide a
digital print of material from which its molecular composition can
be determined1,2.
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Raman spectroscopy has lately been used as an analytical
tool in the biochemical characterization of biological tissues,
including neoplasias, due to advantages such as its sensitivity to
detect small structural changes in the molecules, as well as being
a non-invasive test that does not require much preparation in
data collection1-3. These molecular changes can assist in the early
detection of neoplastic lesions, and in the scanning of lesions that
are not clinically detected, by determining the safe margins for the
excision of tumors, based on the concept that chemical changes
precede the morphologic changes4.
The histopathologic test is the gold standard to diagnose
cutaneous melanoma. It uses a thickness biopsy of the tumor. In
the case of metastatic disease that cannot be clinically detected,
it provides better evaluation and information about the patient’s
prognosis5. However, the histopathological test of these injuries
is not easy due to a relevant amount of lesion that can imitate
melanoma.  The use of markers (HMB-45, S100, Melan-A)
diminish this diagnostic difficulty, but can fail as these antibodies
can also be found in benign lesions5,6. Raman spectroscopy
attempts to diminish the subjectivity in the diagnosis of cutaneous
pigmented lesions.  The aim of this study therefore was to qualify
the Raman spectral data in primary and metastatic cutaneous
melanoma, aiming towards a differential diagnosis.
Methods
The research was approved by the Ethics Committee of
the Federal University of Sao Paulo-UNIFESP (CEP 1642/05).
For the experimental procedure, 10 fragments of normal skin with
no clinical or pathologic alterations, 10 fragments of cutaneous
melanoma, and 9 fragments with lymph nodal metastasis were used.
The samples originated from excisions of primary tumours or
therapeutical lymphectomies.  Patients were selected consecutively
rather than randomly. They were informed of the research and
asked to sign a consent form, authorizing the collection of their
tissue samples.
After the surgical procedure, all samples were identified,
snap-frozen, and stored in liquid nitrogen at minus 77 K in
cryogenic Nalgene® vials, before FT-Raman spectra recording.
For FT-Raman data collection, samples were brought to room
temperature and kept moist in 0.9 % physiological solution to
preserve their structural characteristics. They were then placed in
a windowless aluminum holder for the Raman spectra collection.
Soon after, samples were fixed in 10 % formaldehyde solution for
further histopathological analysis.  A FT-Raman Bruker RFS 100/S
spectrometer was used with Nd:YAG laser at 1064 nm as the
excitation light source.  The laser power on the sample was kept at
300 mW while the spectrometer resolution was set to 4 cm-1.  There
were five collection points per sample.  Spectra of normal skin
and primary melanoma plus metastatic melanoma tissues were
recorded with 100 and 150 scans, respectively.  OPUS software
(Bruker) was used to evaluate spectral characteristics in the
region from 800 cm-1 to 1800 cm-1.  Before the visual evaluation,
all spectra were baseline corrected and vector normalized. For
analysis, the Raman spectra were first pre-processed by correcting
the base line and performing vector normalization using Minitab
software (Minitab® 15.1.1.0).
Once the entire databases were established, the variables
obtained from specific samples were investigated, and their
capacity to differentiate the groups from a statistical point of
view.  At first, analysis of variance with a constant factor was
used.  This demonstrated that all variables showed an association
with their own group. The next phase of the statistical analysis
was the employment of a discriminating analysis, the results of
which showed a significant differentiation between the three
groups.
After measurement, the samples were fixed in a 10 %
formalin solution and thereafter sent to the Pathological Anatomy
Department of UNIFESP/EPM, for diagnostic confirmation. At
this phase, the samples were regularly processed for the
confection of histological slides by being stained with Hematoxilin
and Eosin.  Thus, each spectrum obtained could be related to a
confirmed histological finding, enabling the formation of spectral
groups to allow for univariate and multivariate analysis.
Results
Ten samples without clinical and histopathological
alterations of different patients were evaluated; 105 spectra were
obtained from this group, and used as the control group. All samples
were histologically diagnosed as normal skin. Ten samples of the
primary melanoma group and nine of the metastasis group were
studied, of which, respectively, 140 and 126 spectra were obtained.
All the spectra were grouped to proceed with the visual analysis,
showing well-defined standards on the three groups, which
indicated a differentiation among them.
Some variables were investigated among the possible
spectra from a statistical point of view.  These variables were based
on information regarding the biochemical compounds present in
biological (skin) tissues analysed through the identification of the
Raman spectra (Figure 1). This identification was based on
Gniadecka et al.7 proposal.
FIGURE 1 – Average Raman spectra of the primary melanoma and
metastatic melanoma
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With visual analysis, compared with normal skin, the
melanoma spectra presented a decrease on the Amide I band,
with spectral area distortion between 1640 and 1670 cm-1, which
suggests change in the proteins’ molecular composition.  On
the 1475 to 1640 cm-1 region, an increase was observed in the
intensity for the melanoma group, corresponding to proteins
and lipids.  In the Raman shift region of 1200 to 1300 cm-1,
corresponding to Amide III and Lipids biomolecules, there was
an increase in the intensity, and on the region representing the
melanin molecule there was also an intensity increase (1300 to
1400 cm-1).  In the region corresponding to the protein band
between 920 to 980 cm-1, there was a decrease in the intensity.
With the metastasis and normal skin group, the alterations on the
bands and peaks were quite similar, although relevant.
The metastasis spectral group presented differences in
relation to the primary melanoma group on the Amide I (1640 to
1670 cm-1) band, where the metastasis groups presented a decrease
in the intensity in relation to the primary melanoma group, an
increase in the Amide III and lipids (1222 to 1300 cm-1), as well as
in the protein area between 900 and 940 cm-1.  On the melanin,
corresponding band there was an increase in the intensity of the
metastasis group (1300 to 1380 cm-1).  Figure 1 shows the spectra
median of the melanoma and metastasis groups. Visually, the
differences on the bands and peaks are discreet.
In order to proceed with the statistical analysis, the
spectra were divided according to the histologic group to which
they belonged.  Inside each group, the spectra were united in
sampling units.  These units were constructed through the average
calculation of the original spectra of each patient in order to
summarize the data and organize their analysis.  Ten sampling units
for normal skin, ten sampling units for primary melanoma and nine
sampling units for the metastasis were obtained.
Following the identification of the biochemical bands
relevant to statistical analysis, the first step was to employ analysis
of variance with a constant factor, revealing that all variables, or
Raman vibrational modes, presented a significant association with
each diagnostic group.
In order to better understand these results, Box plots were
constructed for each vibrational mode analyzed (Bands 1 to 10,
described in Table 1).  These plots clearly showed the distribution
of biomolecules within each group studied.
 
 
Present Study 
Bands 
Normal Skin 
(cm
-1
) 
Metastatic 
Melanoma 
(cm
-1
) 
Primary 
Melanoma 
(cm
-1
) 
Bio molecules 
1 813, 855, 876 834, 855 807, 822, 955, 882 Polysaccharides 
2 921, 940, 957 919, 940, 955 934, 955, 984 
Amino acids, Valine and 
Proline. 
3 1004 1004 1004 Phenylalanine (ring) 
4 
1033, 1047, 
1067, 1096, 1125 
1031, 1067, 1086, 
1127 
1032, 1046, 1079, 
1096, 1121 
 
PO2-, Nucleic Acids 
5 1160, 1168, 1206 1160, 1169, 1210 1158, 1173, 1221 Tyrosine 
6 
1247, 1270, 
1312, 1335, 1343 
1243, 1268, 1302, 
1314, 1339 
1235, 1248, 1316, 
1328, 1341 
Lipids, Proteins (Amide-III) 
7 
1312, 135, 1343, 
1384 
1314, 1339, 1393 1316, 1328, 1341 
Adenine, Phenylalanine and 
Melanin 
8 1451, 1544 1451, 1526,1547 1407, 1451, 1526 Proteins and Lipids 
9 1619 1576, 1588, 1619 1582, 1598, 1621 
DNA (adenine, guanine), 
Phenylalanine, and Melanin 
10 1663, 1748 1661 1663 Lipids, Proteins (Amide-I) 
TABLE 1 – Raman vibrational modes and bio molecules related to the spectra of normal skin, pigmented nevus
and primary melanoma7
This set of figures, where the qualitative description of
all vibrational modes was resumed, showed that the spectra of
the Metastatic Melanoma group obtained the greatest intra-group
difference for all analyzed items, followed by the Primary
Melanoma and then Normal Skin groups.  It is likely that this
difference refers to the significant fluorescence generated by the
tissue due to its high degree of pigmentation.
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FIGURE 2 – Box-plot graph of the Amide I groups, phenylalanine and
DNA, respectively. The variation in the metastasis group is higher than
the primary melanoma group, which is higher than the normal skin group.
The higher heterogeny in the metastasis group indicates a higher variation
between the number of different molecules
Finally, for each vibrational mode, multivariate analysis
of the spectra was calculated.  The multivariate analysis
included the descriptive level calculation.  These results are shown
in Table 2.
Bands Variable Descriptive level 
1 Polysaccharides 0,001 
2 Amino acids, Valine and Proline 0,001 
3 Phenylalanine 0,018 
4 PO2, nucleic acids 0,024 
5 Tyrosine 0,025 
6 Lipids, Proteins, Amide-III 0,026 
7 Adenine and Phenylalanine 0,019 
8 Proteins and Lipids 0,030 
9 DNA 0,020 
10 Amide-I 0,034 
TABLE 2 – Results of the comparison between the groups (normal skin,
primary melanoma, and metastatic melanoma) relating to each of the
variables within the study
The variables Phenylalanine, DNA and Amide I stood
out at the differentiation of the three groups, in agreement with
the classification functions detailed in Tables 3 and 4.
 Function 1 Function 2 
Phenylalanine 10,598 -17,069 
DNA 6,939 6,515 
Amide I -17,173 10,685 
 Groups 
 Normal Skin Primary Melanoma Metastase 
Phenylalanine -37,513 -22,912 3,357 
DNA -2,944 17,882 15,181 
Amide I 36,756 0,600 -22,803 
Constant -11,203 -8,258 -7,285 
TABLE 3 – Coefficients of the discriminating functions based on
phenylalanine, DNA and amide i in normal skin, primary and metastatic
cutaneous melanoma Raman signals
TABLE 4 – Coefficients of the classification functions based on
phenylalanine, DNA and amide i in normal skin, primary and metastatic
cutaneous melanoma Raman signals
Focusing on the differentiation of the three sampling
groups formed according to the characteristics obtained from the
spectra, a discriminant analysis of the data was undertaken.  The
percentage of individuals correctly classified with this criterion was
93.1%, showing the efficiency of the analysis (Figure 3).
In the discriminating analysis, the results presented
significant differentiations between the three groups studied;
the following skin components (variables) deserve attention:
Phenylalanine, DNA and Amide-I (Figure 2).
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The spectra collected from the skin with no alterations
(control group) were similar to those collected previously7,8. The
Amide I band (1640-1700 cm-1) corresponds mainly to the stretch
vibrational mode of the ligations C=O, whereas Amide III
(1222-1362 cm-1), is nominated by the vibration in the ligations
N-H plan and the stretch of C-N.  Both regions thus reflect
the secondary structure of the proteins7.  The lipid structure is
represented by the vibration of CH2 in the region between 1420
to 1500 cm-1.  The bands between 855 and 937 cm-1 are typical of
the collagen spectrum, are due to proline vibration, and stretch
vibration of the C-C in the protein9.
Discussion
This technique did not require wide sample preparation
or pretreatment. Using the FT-Raman technique employing light
sources in the infrared region, the detection of weak Raman
signals became easier due to fluorescence suppression.  Moreover,
the excitation in the near infrared, at 1064 nm, also minimizes
sample photo degradation, allowing the employment of larger
powered densities to compensate weak Raman signals generated
by longer wavelengths.
In previously published data, authors compared the
spectra of malignant and benign pigmented cutaneous: seborrheic
keratosis, pigmented nevi, pigmented basal cell carcinoma and
melanoma, and through visual analysis of the spectra, they could
differ the lesions. Using the neural system, the sensitivity of
melanoma diagnosis was 85 % and the specificity 99 %. The
authors discussed, based on these observations, that the neoplastic
transformation in the tissues, can start cellular changes no matter
FIGURE 3 – The discriminative analysis of data was able to differ 93.1%
of the variables. Through two imaginary lines, the separation of the groups
by similarity can be observed
the kind of tissue involved and the alterations on the amide bands
in the Raman spectra are attributed to the protein conformation10.
In the melanoma group of this study, the alterations visually
examined were similar, diminishing on the Amide I band, with
spectral area distortion between 1640 and 1670 cm-1. However, in
the metastasis groups, this reduction was higher when compared
to the melanoma group.  On the Amide III band, there was an
increase in the intensity, and in the metastasis group, the increase
was more relevant.  It can be concluded that for a cell to become
metastatic, a higher number of protein mutations need to occur.
In the present study, in the regions of Raman shifts 1540
to 1620 cm-1 and 1040 to 1100 cm-1, corresponding to DNA’s
vibrational mode, an increase of spectral intensity was observed
metastatic melanoma and primary melanoma. In the first group,
the intensity gain was stronger. Maybe, this intensity gain of the
metastatic melanoma spectrum in these bands could be related to
an increase in nucleic acids and protein synthesis in malignant
tissues due to an elevated quantity of mitoses and, consequently,
increased duplication of genetic material responsible for the
proliferation of malignant cells compared with primary melanoma.
Similar effect was observed by Mahadevan-Jansen et al.12,
who conducted studies on molecular biology and energy
transformation in the DNA of cancerous and pre-cancerous tissues
using Raman spectroscopy.
The statistical analysis helped to decrease the subjectivity
of the data observation and demonstrated that there is a higher
heterogeny in the metastasis group, indicative that cell clones  can
differ themselves through mutations to the point that they become
more invasive, and so, different from the primary melanoma cells.
In the band corresponding to the melanin, the melanoma group
presented higher intensity, showing a higher production of this
pigment in the neoplasia studied; in the metastasis group, this
increase was more intense at 1360 to 1400 cm-1, showing that
metastatic cells are capable of producing pigment.
The cutaneous melanoma presents a high quantity of
melanin due to characteristics of the neoplasia, making it difficult
to use optical biopsy with  FT-Raman spectroscopy, and therefore,
further studies to enable the diagnosis of pigmented lesions are
necessary.
Certainly, this study will serve, as the basis to use
FT-Raman spectroscopy in the diagnosis of cutaneous melanoma
in vivo, however further research is necessary.
Conclusion
FT-Raman spectroscopy is capable of differentiating
melanoma from its metastasis, as well as from normal skin.
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